We use cookies to improve your experience. By your continued use of this site you accept such use.
Revna Biosciences

  • Multimedia content

  • Images (2)
    • Dr. Yaw Asare-Aboagye, DVM, Board Member, Revna Biosciences
    • Dr Derrick Akpalu, CEO and Co-Founder, Revna Biosciences
  • All (2)
Source: Revna Biosciences |

CORRECTION- Revna Biosciences: A Beacon of Excellence with Dual International Organization for Standardization (ISO) Accreditations in Ghana and West Africa

Revna Biosciences’ accreditation encompasses an extensive array of human sample tests, including those involving urine, swabs, blood, bone marrow, tissue samples, and plasma

Revna Biosciences (www.RevnaBio.com) has carved a niche for itself in Ghana and West Africa by being the first facility in the region to secure dual ISO accreditations: ISO 15189:2022 for clinical diagnostics and ISO 20387:2018 for biobanking. This milestone is a testament to RevnaBio’s unwavering commitment to championing precision medicine…

Revna Biosciences

  • Multimedia content

  • Images (2)
    • Dr. Yaw Asare-Aboagye, DVM, Board Member, Revna Biosciences
    • Dr Derrick Akpalu, CEO and Co-Founder, Revna Biosciences
  • All (2)
Source: Revna Biosciences |

Revna Biosciences: A Beacon of Excellence with Dual International Organization for Standardization (ISO) Accreditations in Ghana and West Africa

Revna Biosciences’ accreditation encompasses an extensive array of human sample tests, including those involving urine, swabs, blood, bone marrow, tissue samples, and plasma

Revna Biosciences (www.RevnaBio.com) has carved a niche for itself in Ghana and West Africa by being the first facility in the region to secure dual ISO accreditations: ISO 15189:2022 for clinical diagnostics and ISO 20387:2018 for biobanking. This milestone is a testament to RevnaBio’s unwavering commitment to championing precision medicine…

Revna Biosciences

  • Multimedia content

  • Images (2)
    • Dr Derrick Akpalu, CEO and Co-Founder, Revna Biosciences
    • Oliva Alberti, Chief Executive Officer, Diatech Pharmacogenetics
  • All (2)
Source: Revna Biosciences |

Revna Biosciences Advances Cancer Research, Adding to Previous Food and Drug Administration (FDA) Approvals

The innovative precision medicine company expands its focus to address unmet oncology needs

Revna Biosciences (RevnaBio) (www.RevnaBio.com), a leading precision medicine company based in Ghana, is making strides in its mission to address unmet needs in cancer care. The company announced that data from its ongoing Ghana FDA-mandated cancer clinical research covering solid and blood cancers has begun supporting product registration. This achievement…

Revna Biosciences

  • Multimedia content

  • Images (3)
    • Simona Grandits, Senior Director, Head-of Sales and Marketing EMEA, QIAGEN
    • Dr. Delese Mimi Darko, the Chief Executive Officer of the FDA, Ghana
    • Derrick Akpalu, CEO and Co-Founder, Revna Biosciences
  • All (3)
Source: Revna Biosciences |

Revna Biosciences receives historic Food and Drugs Authority (FDA) approval for NeuMoDx™ 96 from QIAGEN, the first in Sub-Saharan Africa

The FDA approval secures RevnaBio as the first biomedical company to register/deploy the NeuMoDx platform in Sub-Saharan Africa, hitherto mainly available in Europe, the Middle East, and North America

Ghana-based precision medicine company Revna Biosciences (RevnaBio) (https://RevnaBio.com/) has received historic approval from the Food and Drugs Authority of Ghana (FDA) to use the NeuMoDx™ 96 diagnostics platform supplied by the global biotech company QIAGEN. The registration comes in addition to FDA permissions for RevnaBio to conduct its first set…